We restore endothelial cell function.

Get in touch


Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.

Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany. 

Latest News

307, 2019

“First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment

The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seedfinancing round. The start-up presents a proprietary, innovative technology platform for the development of novel mRNA therapeutics to treat Acute Respiratory Distress Syndrome (ARDS), a severe lung disease. The funds will be used to advance R&D activities and hire additional scientific staff. Investors are the High-Tech Gründerfonds (HTGF), European Business Angel Prof. Dr. Dr. h.c. Detlev Riesner as well as the European Investment Fund and the [...]


Dr. Klaus Giese
Dr. Klaus GieseCEO
Dr. Gerrit Maass
Dr. Gerrit MaassCFO
Dr. Jörg Kaufmann
Dr. Jörg KaufmannCSO
Dr. Oliver Keil
Dr. Oliver KeilCTO


Get in touch

Pantherna Therapeutics GmbH
Neuendorfstrasse 20b
D-16761 Hennigsdorf

Telephone: +49(0)3302-202 240-0
Telefax: +49(0)3302-202 240-1

E-Mail: contact@pantherna-therapeutics.com

Managing Directors: Dr. Klaus Giese, Dr. Jörg Kaufmann, Dr. Gerrit Maass

How can we help?

Please note our Privacy Policy

Public Funding